Elliot Siegel

Immunotherapy: The Silver Bullet Against Cancer?

Dr. Jonathan Simons, Jed Wolchuk, Pam Sharma, Dr. Charles Drake, Elliot Siegel, TJ Sharp, Mary, Dr. William Coley, Jim Allison, Keith Black, Don Coffey, Magic Johnson, Tom Frye, Eleanor Roosevelt, Adlai Stevenson, Dr. Howard Sewell, Carl June, Drew Pardola

Hosted by Prostate Cancer Foundation President Dr. Jonathan Simons, a panel of leading oncologists and industry experts detailed the transformative impact of checkpoint inhibitors, which extended survival for terminal melanoma patients from months to years and triggered 20% cure rates. While the discussion highlighted expanding efficacy in lung and kidney cancers, the group identified critical barriers regarding "cold" tumors, inefficient serial trial designs, and federal funding disparities that threaten early-career research. The panelists concluded by advocating for parallel testing of combination therapies, revised FDA endpoints to accelerate approvals, and increased government investment to bridge the gap between immunological discovery and clinical application.